Your browser doesn't support javascript.
loading
Research advances of PEGylation modification of albumin as drug carrier / 药学实践杂志
Journal of Pharmaceutical Practice ; (6): 241-245,265, 2014.
Article in Chinese | WPRIM | ID: wpr-790326
ABSTRACT
Albumin is an ideal drug carrier , but its application was limited because of the shortcomings of short half -life and susceptible to enzymatic degradation in vivo .However, according to its structural features , albumin has a plurality of modification sites, which can be modified by PEG modifier to extend the cycle time and obstruct the action of the enzyme .Currently, the PEG-mod-ified albumin is still in the research stage , and there have been many studies about PEG-modified albumin , such as the role of PEG modification , the effects on albumin and its preparations and the modification sites selection .The article reviewed the related studies a-bout the PEGylation of albumin .

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Journal of Pharmaceutical Practice Year: 2014 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Journal of Pharmaceutical Practice Year: 2014 Type: Article